格隆汇6月24日丨康哲药业(00867.HK)公告,公司建议将其普通股以介绍方式于新加坡证券交易所有限公司("新交所")作第二上市。建议第二上市(倘落实进行)将不涉及增发新股,其后股份将继续于香港联合交易所有限公司作主要上市及买卖。于2025年6月24日,公司接获中国证券监督管理委员会就建议第二上市发出境外发行上市备案通知书。董事相信,完成建议第二上市后,将使公司能够进入新加坡证券市场。预期此举将...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.